Press releases Archives - Page 2 of 13

Feb

2026

PRESS RELEASE – Lund, February 12th, 2026 – Nature Microbiology publishes the paper ‘’Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial.’’

Hamlet Biopharma

This groundbreaking study introduces an entirely new approach to managing recurrent urinary tract infections. Instead of killing the bacteria, the tre...

Feb

2026

PRESS RELEASE – Lund, February 11th, 2026 – Monthly investor meeting on the 13th of February when Hamlet BioPharma is releasing it’s Q2 report

Hamlet Biopharma

Newsletter, Press releases

Hamlet BioPharma invites you to our February investors’ meeting to be held on the 13th of February 2026, at 12:00. Please click on the link below to p...

Feb

2026

PRESS RELEASE – Lund, February 3rd, 2026 – Collaboration agreement between Hamlet BioPharma and Immunoforge in South Korea

Hamlet Biopharma

Newsletter, Press releases

Hamlet BioPharma has signed an agreement with the Korean biotech company ImmunoForge, to develop novel administration technology for the peptide drug ...

Jan

2026

PRESS RELEASE – Lund 27 January 2026 – 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗡𝗼𝘃𝗲𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿

Hamlet Biopharma

Newsletter, Press releases

We warmly welcome you to the Symposium on “𝗡𝗼𝘃𝗲𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿.” The invited speakers are leading international scientists with...

Jan

2026

PRESSRELEASE – Lund 16 January 2026 – Invitation to digital meeting focusing on novel strategies for treating bacterial infections without antibiotics

Hamlet Biopharma

Newsletter, Press releases

Welcome to Hamlet BioPharma’s monthly digital meeting on January 21 at 12:00, held the same day as the Davos Summit discusses ‘’The Fragile Future of ...

Dec

2025

PRESSRELEASE – Lund 18 December, 2025 – The HAMLET project featured in Cancerfonden’s Christmas Campaign

Hamlet Biopharma

Newsletter, Press releases

The Swedish Cancer Society, Cancerfonden, is a powerful and important research support organization in Sweden. Based mainly on donations, Cancerfonden...

Dec

2025

Pressmeddelande – Lund 4 december, 2025 – Kommuniké från årsstämma i Hamlet BioPharma AB och efterföljande styrelsemöte

Hamlet Biopharma

Newsletter, Press releases

Vid årsstämma i Hamlet BioPharma AB, org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) den 4 december 2025 fattades de beslut som beskrivs neda...

Nov

2025

Nyhetsbrev – FDA ger Hamlet BioPharma pivotal status för avgörande Fas III studie i blåscancer

Hamlet Biopharma

Newsletter, Press releases

Federal and Drug Administration i USA (FDA) har som tidigare meddelats lämnat skriftlig feedback som stöder Hamlet BioPharmas planerade Fas III‑studie...

Nov

2025

Q1 Interim Report July – September 2025

Hamlet Biopharma

Financial, Newsletter, Press releases

...

Nov

2025

Hamlet BioPharma bjuder in till digitalt investerarmöte den 14 november 12.00

Hamlet Biopharma

Newsletter, Press releases

Klicka på länken nedan för att delta. Det går bra att ställa frågor till bolaget genom att e-posta dem till: fraga@investorstudios.se. Sändningen star...